Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Urso in Primary Sclerosing Cholangitis
NCT00059202Phase 3Terminated
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jul 2002
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in Primary Sclerosing Cholangitis (PSC), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jul 2002; status: terminated.
02
Drugs
ursodeoxycholic acid
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT00059202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059202.